| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 21
| Issue : 2 | Page : 96-99 |
|
|
Anti-N-Methyl-D-Aspartate receptor encephalitis in pediatrics: A review of clinical manifestations, treatment, and prognosis
Sawsan Ali Hussein, Basma Adel Ibrahim, Wasnaa Hadi Abdullah
Department of Pediatrics, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq
Correspondence Address:
Dr. Wasnaa Hadi Abdullah
Department of Pediatrics, College of Medicine, Al-Mustansiriyah University, Baghdad
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mj.mj_6_22
|
|
|
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR) is a severe autoimmune disease caused by the development of immunoglobulin G antibodies against the NMDAR's GluN1 subunit in the cerebrospinal fluid. It is characterized by a wide range of clinical features including psychological manifestations, dyskinesia, and epileptic seizures. Intravenous methylprednisolone, intravenous immunoglobulin, and plasma exchange are the first-line treatments. Early diagnosis, treatment, monitoring, and follow-up of the disease are crucial as it results in favorable prognosis. In the pediatric age group, relapse is possible. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
